We are driven to make a difference to global health
P95 is a leading global provider of comprehensive clinical trial services, epidemiology, and real-world evidence (RWE) solutions, with a specialized focus on vaccine development and infectious diseases. We are:
founded in 2011
more than 300 staff
headquartered in belgium, operating on 5 continents
providing tailored clinical research across 30 countries
trusted by global organizations
our locations
We are headquartered in Belgium, with regional hubs on 5 continents, and offices in Austria, Colombia, Ghana, France, Kenya, Morocco, The Netherlands, South Africa, Thailand, and the USA. Our international team is based across over 30 countries.
our history
Learn more about our history and 25+ years of combined experience.
2011
- Foundation year, providing specialized consultancy services in pharmacovigilance and epidemiology, Leuven, Belgium
2015
- Established a data analytics center
2021
- Reacting to the challenges of the COVID-19 pandemic, P95 grew and expanded to new regions
- Acquired Pallas (Netherlands)
- First non-EU office (Colombia)
2023
- Became an Ampersand portfolio company
- First office in SE Asia (Thailand)
- Acquired OnQ Research enhancing portfolio with valuable clinical trial experience (South Africa)
2024
- First office in USA (North Carolina)
- Acquired 4Clinics (France) expanding clinical capabilities
- Acquired Assign DMB (Austria) expanding data management and biostatistics services